GOG 213: Maintenance Bevacizumab in Platinum Sensitive Recurrence Last updated on Jul 28, 2024 Previous Primary Treatment of High-Grade Ovarian/Fallopian Tube Carcinoma Next MITO 16B: Bevacizumab Maintenance with Platinum Doublets in Platinum-Sensitive Recurrence